Increased bioaffinity and anti-inflammatory activity of florfenicol nanocrystals by wet grinding method

References

• Afolabi, A., Akinlabi, O., and Bilgili, E., 2014. Impact of process parameters on the breakage kinetics of poorly water-soluble drugs during wet stirred media milling: a microhydrodynamic view. European journal of pharmaceutical sciences, 51, 75–86.
   PubMed Web of Science ®Google Scholar
• Basa, S., et al., 2008. Production and in vitro characterization of solid dosage form incorporating drug nanoparticles. Drug development and industrial pharmacy, 34 (11), 1209–1218.
   PubMed Web of Science ®Google Scholar
• Bilgili, E. and Afolabi, A., 2012. A combined microhydrodynamics-polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media milling. International journal of pharmaceutics, 439 (1–2), 193–206.
   PubMed Web of Science ®Google Scholar
• Brough, C. and Williams, R.O., 2013. Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery. International journal of pharmaceutics, 453 (1), 157–166.
   PubMed Web of Science ®Google Scholar
• Ci, X., et al., 2008. Ceftiofur impairs pro-inflammatory cytokine secretion through the inhibition of the activation of NF-kappaB and MAPK. Biochemical and biophysical research communications, 372 (1), 73–77.
   PubMed Web of Science ®Google Scholar
• Ci, X.X., et al., 2011. Florfenicol inhibits allergic airway inflammation in mice by p38 MAPK-mediated phosphorylation of GATA 3. Clinical immunology, 138 (2), 231–238.
   PubMed Web of Science ®Google Scholar
• Gao, L., et al., 2013. Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs. Pharmaceutical research, 30 (2), 307–324.
   PubMed Web of Science ®Google Scholar
• Giebelen, I.A., et al., 2007. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock, 28 (6), 700–703.
   PubMed Web of Science ®Google Scholar
• Kesisoglou, F., Panmai, S., and Wu, Y., 2007. Nanosizing – oral formulation development and biopharmaceutical evaluation. Advanced drug delivery reviews, 59 (7), 631–644.
   PubMed Web of Science ®Google Scholar
• Knieke, C., et al., 2015. Sub-100 micron fast dissolving nanocomposite drug powders. Powder technology, 271, 49–60.
   Web of Science ®Google Scholar
• Kohno, K., et al., 2008. Anti-inflammatory and immunomodulatory properties of 2-amino-3H-phenoxazin-3-one. Biological & pharmaceutical bulletin, 31 (10), 1938–1945.
   PubMed Web of Science ®Google Scholar
• Lee, J., 2003. Drug nano- and microparticles processed into solid dosage forms: physical properties. Journal of pharmaceutical sciences, 92 (10), 2057–2068.
   PubMed Web of Science ®Google Scholar
• Li, M., et al., 2016. Nanomilling of drugs for bioavailability enhancement: a holistic formulation-process perspective. Pharmaceutics, 8 (2), 17.
   PubMed Web of Science ®Google Scholar
• Lu, Y., et al., 2012. Phase solubility behavior of hydrophilic polymer/cyclodextrin/lansoprazole ternary system studied at high polymer concentration and by response surface methodology. Pharmaceutical development and technology, 17 (2), 236–241.
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge, E.M. and Liversidge, G.G., 2008. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicologic pathology, 36 (1), 43–48.
   PubMed Web of Science ®Google Scholar
• Minamino, T. and Komuro, T., 2006. Regeneration of the endothelium as a novel therapeutic strategy for acute lung injury. Journal of clinical investigation, 116 (9), 2316–1319.
   PubMed Web of Science ®Google Scholar
• Mishra, P.R., et al., 2009. Production and characterization of hesperetin nanosuspensions for dermal delivery. International journal of pharmaceutics, 371 (1–2), 182–189.
   PubMed Web of Science ®Google Scholar
• Monteiro, A., Afolabi, A., and Bilgili, E., 2013. Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect. Drug development and industrial pharmacy, 39 (2), 266–283.
   PubMed Web of Science ®Google Scholar
• Müller, R.H., Gohla, S., and Keck, C.M., 2011. State of the art of nanocrystals—special features, production, nanotoxicology aspects and intracellular delivery. European journal of pharmaceutics and biopharmaceutics, 78 (1), 1–9.
   PubMed Web of Science ®Google Scholar
• Müller, R.H., Jacobs, C., and Kayser, O., 2001. Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Advanced drug delivery reviews, 47 (1), 3–19.
   PubMed Web of Science ®Google Scholar
• Müller, R.H. and Keck, C.M., 2012. Twenty years of drug nanocrystals: where are we, and where do we go? European journal of pharmaceutics and biopharmaceutics, 80 (1), 1–3.
   PubMed Web of Science ®Google Scholar
• Müller, R.H. and Peters, K., 1998. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size reduction technique. International journal of pharmaceutics, 160 (2), 229–237.
   Web of Science ®Google Scholar
• Noyes, A.A. and Whitney, W.R., 1897. The rate of solution of solid substances in their own solutions. Journal of the American Chemical Society, 19 (12), 930–934.
   Google Scholar
• Peltonen, L. and Hirvonen, J., 2010. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. Journal of pharmacy and pharmacology, 62 (11), 1569–1579.
   PubMed Web of Science ®Google Scholar
• Peters, K., 2000. Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection. Journal of antimicrobial chemotherapy, 45 (1), 77–83.
   PubMed Web of Science ®Google Scholar
• Rabinow, B.E., 2004. Nanosuspensions in drug delivery. Nature reviews drug discovery, 3 (9), 785–796.
   PubMed Web of Science ®Google Scholar
• Shah, D.A., Murdande, S.B., and Dave, R.H., 2016. A review: pharmaceutical and pharmacokinetic aspect of nanocrystalline suspensions. Journal of pharmaceutical sciences, 105 (1), 10–24.
   PubMed Web of Science ®Google Scholar
• Shen, J., et al., 2017. A liposome encapsulated ruthenium polypyridine complex as a theranostic platform for triple-negative breast cancer. Nano letters, 17 (5), 2913–2920.
   PubMed Web of Science ®Google Scholar
• Singh, A. and Van den Mooter, G., 2016. Spray drying formulation of amorphous solid dispersions. Advanced drug delivery reviews, 100, 27–50.
   PubMed Web of Science ®Google Scholar
• Sunil Reddy, P., Sudhakar Babu, K., and Kumar, N., 2013. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation. Journal of chromatographic science, 51 (3), 242–249.
   PubMed Web of Science ®Google Scholar
• Thiry, J., et al., 2011. Efficacy and safety of a new 450 mg/ml florfenicol formulation administered intramuscularly in the treatment of bacterial bovine respiratory disease. Veterinary record, 169 (20), 526–526.
   PubMed Web of Science ®Google Scholar
• Van Eerdenbrugh, B., Van den Mooter, G., and Augustijns, P., 2008. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. International journal of pharmaceutics, 364 (1), 64–75.
   PubMed Web of Science ®Google Scholar
• Verma, S., et al., 2011. Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening. International journal of pharmaceutics, 406 (1–2), 145–152.
   PubMed Web of Science ®Google Scholar
• Verma, S., Gokhale, R., and Burgess, D.J., 2009. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. International journal of pharmaceutics, 380 (1–2), 216–222.
   PubMed Web of Science ®Google Scholar
• Woitiski, C.B., et al., 2009. Colloidal carrier integrating biomaterials for oral insulin delivery: influence of component formulation on physicochemical and biological parameters. Acta biomaterialia, 5 (7), 2475–2484.
   PubMed Web of Science ®Google Scholar
• Wu, L., Zhang, J., and Watanabe, W., 2011. Physical and chemical stability of drug nanoparticles. Advanced drug delivery reviews, 63 (6), 456–469.
   PubMed Web of Science ®Google Scholar
• Yamaoka, K., Nakagawa, T., and Uno, T., 1978. Application of Akaike’s information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of pharmacokinetics and biopharmaceutics, 6 (2), 165–175.
   PubMedGoogle Scholar
• Yildiz, Z.I., Celebioglu, A., and Uyar, T., 2017. Polymer-free electrospun nanofibers from sulfobutyl ether7-beta-cyclodextrin (SBE7-β-CD) inclusion complex with sulfisoxazole: fast-dissolving and enhanced water-solubility of sulfisoxazole. International journal of pharmaceutics, 531 (2), 550–558.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2008. Effects of florfenicol on early cytokine responses and survival in murine endotoxemia. International immunopharmacology, 8 (7), 982–988.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2009. Protective effect of florfenicol on acute lung injury induced by lipopolysaccharide in mice. International immunopharmacology, 9 (13–14), 1525–1529.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2010. Effects of florfenicol on LPS-induced nitric oxide and prostaglandin E2 production in RAW 264.7 macrophages. Fundamental and clinical pharmacology, 25 (5), 591–598.
   PubMed Web of Science ®Google Scholar
• Zhao, B., et al., 2018. Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A. International journal of pharmaceutics, 535 (1–2), 164–171.
   PubMed Web of Science ®Google Scholar